SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-153197
Filing Date
2020-05-27
Accepted
2020-05-27 17:03:36
Documents
6
Period of Report
2020-05-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d936690d8k.htm 8-K 38950
2 EX-2.1 d936690dex21.htm EX-2.1 132944
3 EX-10.1 d936690dex101.htm EX-10.1 94619
4 EX-10.2 d936690dex102.htm EX-10.2 22347
5 EX-99.1 d936690dex991.htm EX-99.1 17576
6 GRAPHIC g936690g0527193036402.jpg GRAPHIC 5031
  Complete submission text file 0001193125-20-153197.txt   314653
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 20916122
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences